TRANSGENE (TRGNY) Announces a Follow-on Investment in Jennerex, Inc.
5/28/2013 9:51:16 AM
More...
|
TRANSGENE (TRGNY) Announces Completion of Enrollment in TRAVERSE, a Phase 2b Clinical Trial of Pexa-Vec for the Treatment of Liver Cancer
5/21/2013 10:53:02 AM
More...
|
TRANSGENE (TRGNY) Announces its Invesment in ElsaLys Biotech, a New Antibody Company Created by Former Executives
5/21/2013 9:50:01 AM
More...
|
The Start-Up ElsaLys Biotech, a New Player in the Therapeutic Monoclonal Antibody Arena, Announces the First Round of Financing With TRANSGENE (TRGNY) and Sofimac Partners
5/17/2013 9:55:15 AM
More...
|
TRANSGENE (TRGNY): First Quarter 2013 Financial Report
4/22/2013 10:10:03 AM
More...
|
TRANSGENE (TRGNY) to Present New Data on TG1050 and TG4040 to Treat Chronic Hepatitis B and C at EASL 2013
4/8/2013 10:43:31 AM
More...
|
TRANSGENE (TRGNY) to Present New Data on TG1050 and TG4040 to Treat Chronic Hepatitis B and C at EASL 2013
4/8/2013 10:16:04 AM
More...
|
Sanofi (France) (SAN.PA) and TRANSGENE (TRGNY) Ink Immunotherapy Pact
3/25/2013 7:20:47 AM
More...
|
TRANSGENE (TRGNY) Won't Sign TG4040 Partnership Soon, CEO Says
2/8/2013 8:17:04 AM
More...
|
TRANSGENE (TRGNY) Announces its Financial Calendar for 2013
1/16/2013 9:49:51 AM
More...
|
|